AptarGroup, Inc. (ATR) is a publicly traded Healthcare sector company. As of May 21, 2026, ATR trades at $115.24 with a market cap of $7.39B and a P/E ratio of 19.45. ATR moved +1.27% today. Year to date, ATR is -6.29%; over the trailing twelve months it is -27.29%. Its 52-week range spans $103.23 to $178.03. Analyst consensus is buy with an average price target of $145.80. Rallies surfaces ATR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AptarGroup drops after Q1 profit and margins slide on pharma destocking: AptarGroup shares fell May 1, 2026 after it reported Q1 2026 adjusted EPS of $1.19 versus $1.30 a year earlier, alongside a lower adjusted EBITDA margin of 19.2% vs. 20.7%. The company cited emergency-medicine destocking and operational disruptions as key drags despite sales rising 11% to $982.9 million.
| Metric | Value |
|---|---|
| Price | $115.24 |
| Market Cap | $7.39B |
| P/E Ratio | 19.45 |
| EPS | $5.91 |
| Dividend Yield | 0.48% |
| 52-Week High | $178.03 |
| 52-Week Low | $103.23 |
| Volume | 185 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.87B |
| Net Income | $386.60M |
| Gross Margin | 0.00% |
5 analysts cover ATR: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $145.80.